The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature, and other conventional methods are ineffective. GlobalData uses proprietary data and analytics to provide a comprehensive report on the topical absorbable hemostats devices market, including market shares of different players within Norway. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the topical absorbable hemostats market in Norway was Ethicon followed by B. Braun Melsungen, Teleflex, Z-Medica, Gelita Medical, CR Bard, Medtronic, Pfizer and Meril Life Sciences.
Topical absorbable hemostats are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon. TAH products are often plant or gelatin based and act as mechanical barriers and/or help with vasoconstriction and a platform for platelet aggregation to slow the flow of blood and give the patient’s body time to form a clot. Flowable hemostats or fibrin sealants are tracked under the tissue sealants and adhesives market. Hemostats include active hemostats (thrombin-based hemostats), and combination and passive hemostats (oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, polysaccharide-based hemostats, collagen-based hemostats). Oxidized regenerated cellulose-based hemostats are poly anions that contain polyanhydroglucuronic acid as a functional unit to aid in the platelet adhesion and aggregation process resulting in coagulation. Gelatin is a protein developed by denaturing the collagen and polymerizing with nitrogen to produce a porous scaffold. Polysaccharide based hemostats are purified plant derived starch. Collagen is a protein derived from animal source.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the topical absorbable hemostats devices market within Norway was expected to be over $6.569e+006m in 2022.
For the latest complete market share analysis of topical absorbable hemostats device market in Norway, buy the report here.